Sort
82,697 grants matching “vaccine development”
Structural Biology of Influenza Epitopes
$858,551Audray Harris · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Center for the Study of Innate Immunity to HCV Infection
$858,518Michael J Gale · University Of Washington · U19 · FY2012 · AI
Center for the Study of Innate Immunity to HCV Infection
$858,518Michael J Gale · University Of Washington · U19 · FY2014 · AI
A novel vaccine: botulinum neurotoxin subunit on a viral carrier.
$858,482Matthias Johannes Schnell · Molecular Targeting Technologies, Inc. · R42 · FY2013 · AI
Optimizing Adjuvants and Needle Free Delivery Methods for Oral HIV Vaccination
$858,438Rama Rao Amara · Emory University · R01 · FY2016 · DE
Structure-function studies of the membrane-interacting domains of HIV-1 Env spike
$858,313Bing Chen · Boston Children'S Hospital · R01 · FY2016 · AI
Cytokine Gene Therapy of Cancer - Preclinical Studies
$858,309Walter J Storkus · University Of Pittsburgh At Pittsburgh · P01 · FY2009 · CA
Low cost molecular assay for HIV
$858,212Bertrand Lemieux · Biohelix Corporation · R44 · FY2011 · AI
Task A23: Ferret Models for the Evaluation of Universal Influenza Vaccines and Vaccination Strategies
$858,192Swagata Kar · Bioqual, Inc. · N01 · FY2018 · AI
Human Monoclonal Antibodies for Encephalitic Alphaviruses
$858,139James E Crowe · Vanderbilt University Medical Center · R01 · FY2022 · AI
Cancer Immunotherapy Clinical Trials
$858,075Christopher Heery · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
KSHV Subunit Vaccine Candidates to Elicit Potent Humoral Immune Reponses against KSHV Infection
$858,048Javier Gordon Ogembo · Beckman Research Institute/City Of Hope · R01 · FY2022 · AI
Impact of HIV, oral microbiome and mycobiome on oral HPV persistence
$858,030Robert D. Burk · Albert Einstein College Of Medicine · R01 · FY2022 · DE
Impact of the COVID-19 Pandemic on Patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias
$857,976John Hsu · Massachusetts General Hospital · U01 · FY2021 · AG
International Collaboration in Infectious Disease Research on Lassa fever
$857,925Robert F Garry · Tulane University Of Louisiana · U19 · FY2018 · AI
Vector Biological Studies in Leishmaniasis
$857,801David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Task A38: Establishment of Small Animal Models for Screening Medical Countermeasures for the 2019 Novel Coronavirus (2019-nCoV)
$857,754Ralph Baric · Univ Of North Carolina Chapel Hill · N01 · FY2020 · AI
Papillomavirus Virion Proteins and Vaccines
$857,735Douglas R. Lowy · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Elicitation of HIV Broadly Neutralizing Antibodies from Engineered B cells
$857,707James Even Voss · Scripps Research Institute, The · R01 · FY2025 · AI
Diet and Duration of Cervical HPV Infection
$857,678Marc T Goodman · University Of Hawaii At Manoa · R01 · FY2009 · CA
Comparative Medicine Shared Resource
$857,373Gordon Roble · Fred Hutchinson Cancer Center · P30 · FY2025 · CA
Influenza pathogenesis in pregnancy
$857,164Kristina M Adams Waldorf · University Of Washington · R01 · FY2023 · AI
Active Immunization for Treating Methamphetamine Abuse
$857,145S. Michael Owens · Univ Of Arkansas For Med Scis · U01 · FY2007 · DA
Trans-complementing papillioma virus for AIDS vaccine
$857,135Marie-Claire Elisabeth Gauduin · Texas Biomedical Research Institute · R01 · FY2017 · AI
High-throughput mapping of antigen specificity to B-cell-receptor sequence for characterizing antibody responses in HIV-vaccinated and infected individuals
$857,109Ivelin Georgiev · Vanderbilt University Medical Center · R01 · FY2022 · AI